These pathologically activated glia can further secrete various neuro and glial excitatory substances including CCL1 and CXCL12, leading to not only neuronal sensitization, i.e., enhanced neural excitability facilitating pain processing, but also more glial proliferation and activation, which is implicated in bone cancer pain [3, 33]. Here, CXCL12 is linked to bone neoplasm.